Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Joyce Nakatumba‐Nabende

Biographic Data

ID9120459
NAMEJoyce Nakatumba‐Nabende
GIVEN NAMESJoyce
FAMILY NAMENakatumba‐Nabende
SIGNATURENABENDE J N
AFFILIATIONSMakerere University
ORCID0000-0002-0108-3798
VERIFIEDYes
TOTAL WORKS4
TOTAL CITATIONS0
WORKS AS AUTHOR4
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2024
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Durable viral suppression in the dolutegravir era

    Open Access•Maria Magdalene Namaganda, Joyce Nakatumba Nabende et al.•ARTICLE•Frontiers in Public Health•2026

    Despite widespread rollout of dolutegravir-based (DTG) antiretroviral therapy (ART) in East Africa, viral non-suppression, advanced HIV disease (AHD), and multimorbidity persist, reflecting gaps in service response rather than regimen potency alone. In Uganda’s The AIDS Support Organization (TASO) routine-care cohort (2014–2024; n = 54,348 people living with HIV), integrase inhibitor uptake is near universal, yet AHD remains common, and tuberculo…

  • Decade-long antiretroviral therapy in Uganda

    Open Access•Maria Magdalene Namaganda, Stathis Gennatas et al.•ARTICLE•PLOS Global Public Health•2026

    The scale-up of antiretroviral therapy (ART) has transformed the HIV epidemic in sub-Saharan Africa, yet longitudinal public health insights from national programmatic cohorts remain scarce. As global targets move toward epidemic control and elimination of virological failure, understanding how profiles and outcomes of people living with HIV (PLWH) evolve in real-world settings is essential. The AIDS Support Organisation (TASO), Uganda’s largest …

  • Data science without borders

    Open Access•Agnes Kiragga, Agnes N Kiragga et al.•ARTICLE•Frontiers in Public Health•2025

    Background: Effective public health data science in Africa requires a comprehensive understanding of institutional capabilities across multiple dimensions. This study conducted a multidimensional assessment of three African health institutions to examine the availability of health data, healthcare training, data governance needs, and infrastructure capabilities, to inform the use of data science tools to address health challenges. Methods: The st…

  • Barriers to global engagement for African researchers

    Open Access•Bamba Gaye, Nzechukwu M Isiozor et al.•ARTICLE•Journal of Global Health•2024

    African researchers continue to face numerous barriers that limit the global dissemination and advancement of their research. These include high open-access publication fees, requirements for publishing in high-impact journals, inability to attend or host international conferences, and limited access to published papers and resources. In this viewpoint, we focus on the specific challenge of attending [...]

No prominent works on this page.

  • Barriers to global engagement for African researchers

    Open Access•Bamba Gaye, Nzechukwu M Isiozor et al.•ARTICLE•Journal of Global Health•2024

    African researchers continue to face numerous barriers that limit the global dissemination and advancement of their research. These include high open-access publication fees, requirements for publishing in high-impact journals, inability to attend or host international conferences, and limited access to published papers and resources. In this viewpoint, we focus on the specific challenge of attending [...]

  • Data science without borders

    Open Access•Agnes Kiragga, Agnes N Kiragga et al.•ARTICLE•Frontiers in Public Health•2025

    Background: Effective public health data science in Africa requires a comprehensive understanding of institutional capabilities across multiple dimensions. This study conducted a multidimensional assessment of three African health institutions to examine the availability of health data, healthcare training, data governance needs, and infrastructure capabilities, to inform the use of data science tools to address health challenges. Methods: The st…

  • Durable viral suppression in the dolutegravir era

    Open Access•Maria Magdalene Namaganda, Joyce Nakatumba Nabende et al.•ARTICLE•Frontiers in Public Health•2026

    Despite widespread rollout of dolutegravir-based (DTG) antiretroviral therapy (ART) in East Africa, viral non-suppression, advanced HIV disease (AHD), and multimorbidity persist, reflecting gaps in service response rather than regimen potency alone. In Uganda’s The AIDS Support Organization (TASO) routine-care cohort (2014–2024; n = 54,348 people living with HIV), integrase inhibitor uptake is near universal, yet AHD remains common, and tuberculo…

  • Decade-long antiretroviral therapy in Uganda

    Open Access•Maria Magdalene Namaganda, Stathis Gennatas et al.•ARTICLE•PLOS Global Public Health•2026

    The scale-up of antiretroviral therapy (ART) has transformed the HIV epidemic in sub-Saharan Africa, yet longitudinal public health insights from national programmatic cohorts remain scarce. As global targets move toward epidemic control and elimination of virological failure, understanding how profiles and outcomes of people living with HIV (PLWH) evolve in real-world settings is essential. The AIDS Support Organisation (TASO), Uganda’s largest …

Cohort (2 works) · Global Health and Surgery (2 works) · HIV-related health complications and treatments (2 works) · HIV/AIDS drug development and treatment (2 works) · HIV/AIDS Research and Interventions (2 works) · Public health (2 works) · Socioeconomic status (2 works) · Alliance (1 work) · Antiretroviral therapy (1 work) · Artificial Intelligence in Healthcare and Education (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae